BSE Live
Feb 11, 16:01Prev. Close
1512.75
Open Price
1514.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 11, 15:57Prev. Close
1510.30
Open Price
1530.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1498.80 (11)
| Cash Flow of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 224.68 | 369.84 | 342.45 | 223.86 | 397.37 | |
| Net CashFlow From Operating Activities | 385.25 | 371.17 | 401.09 | 325.27 | 250.67 | |
| Net Cash Used In Investing Activities | -164.76 | -275.76 | -287.34 | -299.57 | 399.31 | |
| Net Cash Used From Financing Activities | -45.87 | -53.46 | -216.76 | -58.82 | 772.00 | |
| Foreign Exchange Gains / Losses | -4.17 | -0.14 | 0.03 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 170.45 | 41.81 | -102.97 | -33.12 | 1,421.98 | |
| Cash And Cash Equivalents Begin of Year | -224.80 | -266.60 | -163.63 | -336.08 | -1,393.67 | |
| Cash And Cash Equivalents End Of Year | -54.35 | -224.80 | -266.60 | -369.20 | 28.32 |
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
09.02.2026
09.01.2026
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y